3ttz
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
[[Image:3ttz.png|left|200px]] | [[Image:3ttz.png|left|200px]] | ||
| - | <!-- | ||
| - | The line below this paragraph, containing "STRUCTURE_3ttz", creates the "Structure Box" on the page. | ||
| - | You may change the PDB parameter (which sets the PDB file loaded into the applet) | ||
| - | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | ||
| - | or leave the SCENE parameter empty for the default display. | ||
| - | --> | ||
{{STRUCTURE_3ttz| PDB=3ttz | SCENE= }} | {{STRUCTURE_3ttz| PDB=3ttz | SCENE= }} | ||
===Crystal structure of a topoisomerase ATPase inhibitor=== | ===Crystal structure of a topoisomerase ATPase inhibitor=== | ||
| - | |||
| - | <!-- | ||
| - | The line below this paragraph, {{ABSTRACT_PUBMED_22041057}}, adds the Publication Abstract to the page | ||
| - | (as it appears on PubMed at http://www.pubmed.gov), where 22041057 is the PubMed ID number. | ||
| - | --> | ||
{{ABSTRACT_PUBMED_22041057}} | {{ABSTRACT_PUBMED_22041057}} | ||
==About this Structure== | ==About this Structure== | ||
| - | [[3ttz]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Staphylococcus_aureus Staphylococcus aureus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3TTZ OCA]. | + | [[3ttz]] is a 2 chain structure of [[Gyrase]] with sequence from [http://en.wikipedia.org/wiki/Staphylococcus_aureus Staphylococcus aureus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3TTZ OCA]. |
| + | |||
| + | ==See Also== | ||
| + | *[[Gyrase|Gyrase]] | ||
==Reference== | ==Reference== | ||
Revision as of 02:59, 27 July 2012
Contents |
Crystal structure of a topoisomerase ATPase inhibitor
Template:ABSTRACT PUBMED 22041057
About this Structure
3ttz is a 2 chain structure of Gyrase with sequence from Staphylococcus aureus. Full crystallographic information is available from OCA.
See Also
Reference
- Sherer BA, Hull K, Green O, Basarab G, Hauck S, Hill P, Loch JT 3rd, Mullen G, Bist S, Bryant J, Boriack-Sjodin A, Read J, Degrace N, Uria-Nickelsen M, Illingworth RN, Eakin AE. Pyrrolamide DNA gyrase inhibitors: Optimization of antibacterial activity and efficacy. Bioorg Med Chem Lett. 2011 Oct 12. PMID:22041057 doi:10.1016/j.bmcl.2011.10.010
